Deep Track Capital »

Onkure Therapeutics Inc-a shares owned by Deep Track Capital

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2025-06-30 $431k 181k 2.39
2025-03-31 $2.3M 524k 4.30
2024-12-31 $4.5M 524k 8.60

More positions owned by Deep Track Capital

Guardant Health (GH)
Ionis Pharmaceuticals (IONS)
Cytokinetics Com New (CYTK)
Akero Therapeutics (AKRO)
Apellis Pharmaceuticals (APLS)
Tarsus Pharmaceuticals (TARS)
Immunovant (IMVT)
Dynavax Technologies Corp Com New (DVAX)
Ocular Therapeutix (OCUL)
89bio (ETNB)
Structure Therapeutics Sponsored Ads (GPCR)
Miragen Therapeutics (VRDN)
Protagonist Therapeutics (PTGX)
Axsome Therapeutics (AXSM)
Vaxcyte (PCVX)

View all positions for Deep Track Capital

Top funds holding Onkure Therapeutics Inc-a

Acorn Capital Advisors
Citadel Advisors
Shay Capital
Vanguard Group
Highbridge Capital Management
Vestal Point Capital
BlackRock
StepStone
Cantor Fitzgerald, L. P.
NEA Management Company
Carlyle
Prosight Management
Renaissance Technologies
Rangeley Capital
Tang Capital Management

View all funds holding Onkure Therapeutics Inc-a